French biotech ImCheck Therapeutics is preparing to showcase encouraging interim results for its investigational monoclonal ...

The market for antibody-drug conjugates (ADCs) in non-small cell lung cancer (NSCLC) is poised for significant growth, ...

Swedish biotech Hansa Biopharma (Nasdaq Stockholm: HNSA) is preparing to reduce its headcount by around one-fifth as part of ...

US late-stage biotech Rocket Pharmaceuticals (Nasdaq: RCKT) saw its shares plummet as much as 64% to $2.25 in pre-market ...

China’s biopharmaceutical sector experienced a notable increase in oncology drug licensing deals in 2024, particularly for ...

Thai healthcare solutions company Zuellig Pharma has announced that Mounjaro (tirzepatide), Eli Lilly’s (NYSE: LLY) ...

Biotech major Biogen (Nasdaq: BIIB) and fellow Cambridge, USA-based City Therapeutics, today announced a strategic ...

Indian biosimilars developer Biocon Biologics, a subsidiary of Biocon Ltd (BSE: 532520, today announced that the UK’s ...

US biotech Syndeio Biosciences has launched with over $90 million in funding and a pipeline of synapse-targeting ...

Baychem, a Swiss peptide and oligonucleotide manufacturer, has announced expansion of its multi-site network, launching major ...

Danish privately-held drugmaker MC2 Therapeutics today announced the appointment of Trine Ahlgreen as chief executive (CEO).

UK biotech Nucleome Therapeutics has appointed Bhavna Hunjan as chief business officer, a move that strengthens its ...